The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code
ARTICLE

Table of shorted AIM shares - week to 06/12/2019

2019-12-07 09:10:50

From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2018 and thus far in 2019 (by net short position %, those in bold not on the list at the start of 2019) – and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...

ARTICLE

Motif Bio – argues Nasdaq “Voluntary Delisting”… but it having been set to be involuntary anyway?...

2019-11-26 11:40:54

Currently AIM and Nasdaq listed Motif Bio (MTFB) argues “Voluntary Delisting from the Nasdaq Capital Market”. Hmmm – what about those Nasdaq ‘deficiency notices’?...

NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW ARTICLE

Motif Bio – lender Hercules starts plug pulling and a tweet that did not age well

2019-02-18 03:05:06

I warned you all in a bearcast last week that the real threat to Motif Bio (MTFB) was that lender Hercules would start to want its money back and that the company’s cash crisis would thus soon become critical. And lo it came to pass.

ARTICLE

Sadly, My Big Disappointment for Medical Pioneer Comes with the Territory

2019-02-14 07:59:01

Hello Share Tasters. I now always add a warning to any piece I do on medical pioneers. Rewards can be huge if a new drug comes on the market, but the licensing authorities have understandably to be very cautious. A share which I commended to your further research a month ago has just suffered a huge disappointment. US regulators have currently rejected the company’s new iclaprim drug…

NEWSFLOW ARTICLE

Take a Look at the Bug-Beating Treatment That Could Win a US Licence in the Next Few Weeks

2019-01-15 01:16:40

Hello Share Crashers. Everyone knows that unless we find new antibiotics, the world will be in an awful mess. The bugs that kill us are becoming immune to antibiotics because we have over-used them. What we need are different antibiotics which germs have not had the chance to get used to...

NEWSFLOW NEWSFLOW NEWSFLOW ARTICLE

Motif Bio has the potential to be a big winner

2015-12-30 09:25:21

The biotech sector isn’t my usual area for investment, but one such company that I’ve been following the progress of with interest is Motif Bio (MTFB).

NEWSFLOW NEWSFLOW ARTICLE

Zak Mir's Bull Call Of The Day No.1: Motif Bio: New Rebound Towards 95p

2015-08-31 00:42:45

Motif Bio (MTFB) is a stock, whose share price jumped from the starting gate in the spring of this year after the IPO, and had essentially never looked back since. The trajectory since the low was made on the daily share chart in April below 30p has been extremely robust.

NEWSFLOW NEWSFLOW

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen